Glucagon-like peptide-1 (GLP-1) AGONIST - Incretin Mimetics - GlobalRPH
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies - Metabolism - Clinical and Experimental
Liraglutide Mechanism of Action for Weight Loss (Obesity) and Diabetes
The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways | Scientific Reports
A narrative review of current trends in liraglutide: insights into the unmet needs in management of type 2 diabetes and obesity | SpringerLink
Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide
The 10+ Benefits of Liraglutide — MyBioHack | Unlock Your Maximus Potential
Liraglutide attenuates diabetes-associated neointima formation and... | Download Scientific Diagram
Effective Switch From Twice-Daily Pre-Mixed Insulin 50/50 to Liraglutide to Achieve a Good Glycemic Control in Type 2 Diabetes | Yanai | Journal of Medical Cases
Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus | Arteriosclerosis, Thrombosis, and Vascular Biology
Comparative effectiveness of liraglutide in the treatment of type 2 di | DMSO
Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes Mellitus - Canadian Journal of Diabetes
Proposed mechanism of action of liraglutide on rat lung tissues.:... | Download Scientific Diagram
Schematic diagram of the mechanism of liraglutide-mediated... | Download Scientific Diagram
Effects of liraglutide (GLP-1 receptor agonist) – Efficacy and Adverse... | Download Scientific Diagram
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist - Katsurada - 2016 - Journal of Diabetes Investigation - Wiley Online Library
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes | Nature Reviews Nephrology
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
Frontiers | GLP-1 based therapeutics: simultaneously combating T2DM and obesity | Neuroscience
Saxenda (liraglutide)
Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists in: Journal of Endocrinology Volume 236 Issue 1 (2018)
Liraglutide – Next-Generation Antidiabetic Medication - Clinical Trials Arena
